The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., Le Goff, C., & Cavalier, E. (2020). Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2020.1769285 ![]() |
![]() ![]() | Cavalier, E., Huyghebaert, L., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., VRANKEN, L., PEETERS, S., Le Goff, C., & LADANG, A. (2020). Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clinical Chemistry and Laboratory Medicine, 58 (2), 197-201. doi:10.1515/cclm-2019-0996 ![]() |
![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). 24,25(OH)2D AS A MARKER OF VITAMIN D DEFICIENCY IN CHILDREN: A RETROSPECTIVE [Poster presentation]. Euromedlab 2019. |
![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). EVALUATION OF PARATHORMONE AND 25-HYDROXYVITAMIN D STATUS IN A LARGE [Poster presentation]. Euromedlab 2019. |
![]() ![]() | LADANG, A., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., & CAVALIER, E. (May 2019). PEDIATRIC REFERENCE INTERVALS FOR BONE ALKALINE PHOSPHATASE ON LIAISON° XL [Poster presentation]. Euromedlab 2019. |
![]() ![]() | Morovat, A., Catchpole, A., MEURISSE, A., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., paddon, M., James, T., & CAVALIER, E. (October 2013). IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clinical Chemistry and Laboratory Medicine, 51 (10), 2009-2018. doi:10.1515/cclm-2012-0531 ![]() |
![]() ![]() | CAVALIER, E., ROUSSELLE, O., FERRANTE, N., CARLISI, I., LE GOFF, C., & Souberbielle, J.-C. (October 2013). Technical and clinical evaluation of the VITROS Immunodiagnostic Products 25-OH Vitamin D Total Assay - comparison with marketed automated immunoassays and a liquid chromatography - tandem mass spectrometry method. Clinical Chemistry and Laboratory Medicine, 51 (10), 1983-1989. doi:10.1515/cclm-2013-0138 ![]() |
![]() ![]() | CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498. ![]() |
![]() ![]() | CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259. ![]() |
![]() ![]() | Schleck, M.-L., LAURENT, T., GADISSEUR, R., CARLISI, I., ROUSSELLE, O., & CAVALIER, E. (May 2013). Evaluation of the third-generation to second-generation PTH ratio on the Liaison XL (DIASORIN) as a marker for parathyroïd carcinoma. Biochimica Clinica, 37 (SS), 161. ![]() |
![]() ![]() | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282. ![]() |
![]() ![]() | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329. ![]() |
![]() ![]() | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279. ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., ROUSSELLE, O., & DELANAYE, P. (17 July 2012). Comparison of two automated 3rd generation PTH assays in different clinical populations [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | FORTUNATO, A., LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., ROUSSELLE, O., FERRANTE, N., & CAVALIER, E. (May 2012). Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA Centaur Total Vitamin D [Poster presentation]. The joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinoly, Florence, Italy. |
![]() ![]() | CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., Koivula, M.-K., & Risteli, J. (May 2012). Observed Ranges for the Healthy Paediatrics in the Serum IDS-ISYS CrossLaps® (SCTX-I) [Poster presentation]. European Calcified Tissue Society 39th Annual Congress, Stockholm, Sweden. |
![]() ![]() | CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., & DELANAYE, P. (March 2012). Difference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients. Osteoporosis International, 23 (Supplement 2), 339. ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., & Chapelle, J.-P. (18 February 2012). Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: Towards the end of a strange story? Clinica Chimica Acta, 413 (3-4), 527-528. doi:10.1016/j.cca.2011.11.014 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034 ![]() |
![]() ![]() | DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact » [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland. |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & Souberbielle, J.-C. (2012). Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clinical Biochemistry, 45, 505-508. doi:10.1016/j.clinbiochem.2012.01.021 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190. ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States. |
![]() ![]() | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036 ![]() |
![]() ![]() | Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56. ![]() |
![]() ![]() | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188. ![]() |
![]() ![]() | Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019 ![]() |